Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
NNIPPON CHEMIPHAR CO.,LTD. logo
4539TSE Standard

NIPPON CHEMIPHAR CO.,LTD.

日本ケミファ Yahoo Finance

Recent & upcoming events

Jul 31
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Jun 16
Shareholder meeting Time TBD
Shareholders' meeting
Add to Google Calendar
May 15
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Sep 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Sep 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Oct 16
Est.
Earnings 2:00 approx.
Q2 earnings
Add to Google Calendar
2027
Jan 1
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
Mar 19
Est.
Earnings 2:00 approx.
Q3 earnings
Add to Google Calendar
Mar 28
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Mar 29
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
Jun 4
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar

KPI highlights

FY26
Revenue ¥33.09B YoY +1.6%
Operating income ¥179M margin 0.5%
Net income ¥198M YoY -32.7%
EPS ¥55 YoY -32.9%
P/E —
ROE 1.0% Equity ratio 39% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Company guidance

FY2027/03 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥35.00B +5.8%
Operating income ¥250M +39.7%
Net income ¥60M -69.7%
EPS ¥17 -69.7%

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q1FY23 Q2FY23 Q3FY23 Q4FY24 Q1FY25 Q2
Revenue ¥7.54B¥7.54B¥7.30B¥8.23B¥7.68B—
Operating income ¥-434M¥-107M¥-192M¥263M¥-459M—
Net income ¥-345M¥79M¥-48M¥73M¥-284M—
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2026）

事業法人 25.1%国内機関 3.9%個人 12.7%その他 8.2%未開示 50.1%202120222023202420252026
事業法人国内機関海外機関個人その他未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

ジャパンソファルシム株式会社 11.9%ジャパンソファルシム株式会社公益財団法人山口記念科学振興財団 8.2%公益財団法人山口記念科学振興財団豊島薬品株式会社 6.6%豊島薬品株式会社日本生命保険相互会社（常任代理人 日 3.9%日本生命保険相互会社（常任代理人 日本マスタートラスト信託銀行株式会社）今村　均 3.5%今村　均日本ケミファ従業員持株会 3.4%日本ケミファ従業員持株会ゼリア新薬工業株式会社 3.3%ゼリア新薬工業株式会社上田八木短資株式会社 3.3%上田八木短資株式会社山口　一城 3%山口　一城山口　礼子 2.9%山口　礼子202120222023202420252026

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
ジャパンソファルシム株式会社 433,000 11.9% Yuho (EDINET)
公益財団法人山口記念科学振興財団 300,000 8.2% Yuho (EDINET)
豊島薬品株式会社 242,000 6.6% Yuho (EDINET)
日本生命保険相互会社 144,000 3.9% Yuho (EDINET)
今村 均 126,000 3.5% Yuho (EDINET)
日本ケミファ従業員持株会 122,000 3.4% Yuho (EDINET)
ゼリア新薬工業株式会社 121,000 3.3% Yuho (EDINET)
上田八木短資株式会社 118,000 3.3% Yuho (EDINET)
山口 一城 110,000 3.0% Yuho (EDINET)
山口 礼子 104,000 2.9% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

6/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 0.4%
✓ Positive operating cash flow ¥620M
✗ ROA improved YoY 0.6% → 0.4%
✓ Operating CF exceeds net income (accrual quality) OCF ¥620M / net income ¥198M
✓ Equity ratio improved* Substitute for the original “decrease in long-term debt” 38.4% → 39.0%
✗ Current ratio improved 2.45× → 2.36×
✓ No dilution (shares outstanding did not increase) 4,261,000 → 4,261,000
✗ Gross margin improved 26.9% → 25.4%
✓ Asset turnover improved 0.65× → 0.66×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio 39.0%
Current ratio 2.4×
Years of positive operating CF 8 of last 10 yrs
Payout ratio 61%
Latest fiscal year result Profit (net income ¥198M)

Performance history

Last 10 years
0億円89億円178億円268億円357億円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 357353342318315325316307326331
Operating income 28.418.514.63.645.648.25-2.41-4.946.061.79
Ordinary income 28.517.015.13.075.8210.20.58-2.194.432.27
Net income 20.511.68.814.364.957.003.39-1.802.941.98
Total assets 470468469459471495486495499500
Equity 174175179174180185185185192195

Indicators & cash flow

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ¥530¥315¥245¥121¥138¥194¥94¥-50¥82¥55
ROE 12.3%6.7%5.0%2.5%2.8%3.8%1.8%-1.0%1.6%1.0%
Operating CF 27.431.922.013.915.018.0-9.162.96-2.656.20
Investing CF -25.0-16.1-9.603.26-10.20.35-3.94-31.4-16.6-6.61
Financing CF 7.87-17.41.10-9.610.29-7.931.4414.5-3.05-16.7
FCF 2.3315.812.417.24.7918.4-13.1-28.4-19.2-0.41

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data